Form D · Pharmaceuticals
ATAI Life Sciences AG
Berlin, 2M · CIK 0001776242
Offering snapshot reported Dec 7, 2020 · SEC filing
- Reported sold
- $18.1M Offering amount: $93.6M
- Investors reported
- 24 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 3, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 7, 2020 | Initial | $18,138,879 | No comparison | 24 | SEC filing |
| Oct 20, 2020 | Amendment | $10,902,196 | $7,781,092vs Jan 23, 2020 | 32 | SEC filing |
| Jan 23, 2020 | Initial | $3,121,104 | No comparison | 12 | SEC filing |
| May 17, 2019 | Initial | $23,441,970 | No comparison | 8 | SEC filing |
| May 17, 2019 | Initial | $30,250,800 | No comparison | 23 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-382461
Source: Form D, filed Dec 7, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christian Angermayer | Executive, Promoter |
| Florian Brand | Executive, Promoter |
| Srinivas Rao | Promoter |
| Lars Wilde | Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
Krausenstrasse 9 10
Berlin, 2M, 10117
Berlin, 2M, 10117